Related Experiment Video
Updated: Nov 28, 2025

08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.4K
What can we learn from brain autopsies in COVID-19?
Shibani S Mukerji1, Isaac H Solomon2
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Neuroscience Letters
|November 28, 2020
Summary
This review examines human autopsy findings in fatal COVID-19 cases. It explores the presence of SARS-CoV-2 in brain tissue and its neuropathological effects, clarifying neurological symptoms in coronavirus disease 2019.
Area of Science:
- Neurology
- Virology
- Pathology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a global health crisis with millions of deaths.
- Extrapulmonary manifestations, particularly neurological symptoms, are increasingly observed in COVID-19 patients.
- The mechanisms behind COVID-19 neurological symptoms and potential SARS-CoV-2 neuroinvasion remain unclear.
Purpose of the Study:
- To review human autopsy findings in fatal COVID-19 cases.
- To investigate the presence of SARS-CoV-2 in human brain and olfactory tissues.
- To summarize the neuropathological consequences of SARS-CoV-2 infection.
Main Methods:
- Analysis of human autopsy data from fatal COVID-19 cases.
- Review of studies investigating SARS-CoV-2 presence in brain and olfactory tissues.
- Synthesis of neuropathological findings and clinical disease manifestations.
Main Results:
- Evidence regarding SARS-CoV-2 presence in human brain tissue is being gathered.
- Neuropathological changes associated with COVID-19 infection are being identified.
- Understanding neuroinvasion potential is crucial for managing neurological complications.
Conclusions:
- Human autopsy studies are vital for understanding COVID-19's neurological impact.
- Further research into SARS-CoV-2 neuroinvasion and neuropathology is necessary.
- Integrating neuropathological findings with clinical data will improve patient management and research direction.

